RecruitingNCT05462366
Omics Sequencing of Specimen Derived From Mother-Infant-Pairs
Sponsor
Zhujiang Hospital
Enrollment
100 participants
Start Date
Jun 22, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
The investigators aim to collect breast-milk and feces from the participants, and apply culture techniques as well as omics sequencing technology to probe into the microbial and metabolomic signature of the specimens.
Eligibility
Max Age: 40 Years
Inclusion Criteria4
- healthy pregnant women aged between 20y and 40y.
- Vaginal birth
- BMI<23.5 before pregnancy
- Infants' birth weight, between 2500g and 4000g.
Exclusion Criteria7
- gestational diabetes
- diagnosis of depressive disorder during pregnancy
- gestational hypertension
- diagnosis of other diseases during pregnancy
- Under probiotics or antibiotic treatment from 3 months prior to pregnancy till 3 months after delivery
- histrory of smoking and drinking alcohol
- history of diarrhea from 3 months prior to pregnancy till 3 months after delivery
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERSample collection
Collect breast-milk and feces from mother-infant-pairs.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05462366
Related Trials
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
NCT071696301 location
Predicting Future Errors During Skill Performance
NCT067072071 location
Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
NCT055822001 location
The ENHANCE Study: taVNS and Psilocybin
NCT058664711 location
Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women
NCT071913532 locations